Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus
Frankfurt Main, Germany
Hospital in Frankfurt, Hessen
Wilhelm-Epstein-Straße 4, 60431 Frankfurt am Main
About Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus
"Wir sind Ihr kompetenter Ansprechpartner in allen Fragen der Gesundheit und Pflege im Rhein-Main-Gebiet. Mit unseren beiden Krankenhäusern in Frankfurt, dem AGAPLESION BETHANIEN KRANKENHAUS und dem AGAPLESION MARKUS KRANKENHAUS, bieten wir höchste medizinische und pflegerische Kompetenz auf dem neuesten wissenschaftlichen und technischen Stand. Als evangelische Krankenhäuser mit langer Tradition und Teil des christlichen Gesundheitskonzerns AGAPLESION legen wir großen Wert auf eine liebevolle und persönliche Versorgung und Pflege unserer Patienten."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
5
Clinical Trials at Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus
During the past decade, Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
2020-12-07
2028-12-31
Recruiting
550
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder
2022-07-07
2025-12-17
Recruiting
160
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
2022-07-22
2030-10-08
Recruiting
715
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
2022-09-19
2030-09-27
Recruiting
550
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus
According to Clinical.Site data, the most researched conditions in "Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus" are
"Crohn's Disease" (2 trials), "Urinary Bladder Neoplasms" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus" in a lesser frequency.
Clinical Trials Intervention Types at Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus
Most popular intervention types in "Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus" are "Drug" (5 trials), "Biological" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Guselkumab" (3 trials), "Placebo" (3 trials), "Cetrelimab" (2 trials), "Golimumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus
The vast majority of trials in "Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus" are
5 trials for "All" genders.
Clinical Trials Status at Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus
Currently, there are NaN active trials in "Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".